In This Article:
Amidst a backdrop of fluctuating global markets, with Europe grappling with rising inflation and policy uncertainties, Sweden's market presents a unique landscape for investors. In this context, companies like Medicover that boast high insider ownership may offer an intriguing stability and growth potential, aligning closely with broader economic resilience and investor confidence in such environments.
Top 10 Growth Companies With High Insider Ownership In Sweden
Name | Insider Ownership | Earnings Growth |
CTT Systems (OM:CTT) | 16.9% | 21.6% |
BioArctic (OM:BIOA B) | 35.1% | 50.5% |
Sileon (OM:SILEON) | 33.3% | 109.3% |
InCoax Networks (OM:INCOAX) | 18% | 104.9% |
KebNi (OM:KEBNI B) | 37.8% | 90.4% |
Calliditas Therapeutics (OM:CALTX) | 11.6% | 53% |
edyoutec (NGM:EDYOU) | 14.6% | 63.1% |
Egetis Therapeutics (OM:EGTX) | 17.6% | 98.2% |
Yubico (OM:YUBICO) | 37.5% | 42.5% |
SaveLend Group (OM:YIELD) | 24.9% | 103.4% |
Let's take a closer look at a couple of our picks from the screened companies.
Medicover
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Medicover AB (publ) operates in the healthcare and diagnostic sectors across Poland, Sweden, and other international markets, with a market capitalization of approximately SEK 29.91 billion.
Operations: The company generates revenue primarily through two segments: Diagnostic Services at €585.20 million and Healthcare Services at €1.26 billion.
Insider Ownership: 11.1%
Medicover, a Swedish growth company with high insider ownership, has shown robust financial performance with first-quarter sales rising to €498.8 million from €419.3 million year-over-year and net income increasing to €6.2 million from €1.5 million. Despite challenges in covering interest payments with earnings, Medicover forecasts significant organic revenue growth exceeding €2.2 billion by 2025 and anticipates earnings to grow by 38.2% annually, outpacing the Swedish market's average.
-
Click here to discover the nuances of Medicover with our detailed analytical future growth report.
-
Upon reviewing our latest valuation report, Medicover's share price might be too optimistic.
Pandox
Simply Wall St Growth Rating: ★★★★☆☆
Overview: Pandox AB, a Swedish hotel property company, specializes in owning, operating, and leasing hotel properties with a market capitalization of approximately SEK 34.86 billion.
Operations: The company generates revenues primarily through two segments: own operation, which brings in SEK 3.24 billion, and rental agreements, contributing SEK 3.76 billion.
Insider Ownership: 12.3%